Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice

  • Authors:
    • Daisaku Hachimine
    • Kazushige Uchida
    • Masanori Asada
    • Akiyoshi Nishio
    • Seiji Kawamata
    • Go Sekimoto
    • Miki Murata
    • Hideo Yamagata
    • Katsunori Yoshida
    • Shigeo Mori
    • Yoshiya Tahashi
    • Koichi Matsuzaki
    • Kazuichi Okazaki
  • View Affiliations

  • Published online on: June 1, 2008     https://doi.org/10.3892/ijo.32.6.1221
  • Pages: 1221-1226
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Chronic inflammation predisposes to cancer. Transforming growth factor (TGF)-β, a multifunctional protein, suppresses the growth of normal colonic epithelial cells, whereas it stimulates the proliferation of cancer cells. Interleukin (IL)-10-deficient mice, which develop colitis and colorectal cancer, show an increased level of plasma TGF-β. Although TGF-β may be a key molecule in the development of colon cancer arising from chronic colitis in IL-10-deficient mice, the role of TGF-β still remains unclear. TGF-β activates not only TGF-β type I receptor (TβRI) but also c-Jun N-terminal kinase (JNK), which converts the mediator Smad3 into two distinctive phosphoisoforms: C-terminally phosphorylated Smad3 (pSmad3C) and linker-phosphorylated Smad3 (pSmad3L). We studied C57BL/6-IL-10-deficient mice (n=18) at 4 to 32 weeks of age. We investigated histology, and pSmad2/3L, pSmad2/3C, and p53 by immunohistochemistry. pSmad3L staining was detected in the cancer cells in all 10 mice with colonic cancer and in the epithelial cells in 7 of 12 mice with colonic dysplasia, but not in the normal or colitic mice. pSmad3c was detected without any significant difference between stages. p53 was weakly stained in a few cancer cells in 5 out of 10 mice. Smad3L signaling plays an important role in the carcinogenesis of chronic colitis in IL-10-deficient mice.

Related Articles

Journal Cover

June 2008
Volume 32 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hachimine D, Uchida K, Asada M, Nishio A, Kawamata S, Sekimoto G, Murata M, Yamagata H, Yoshida K, Mori S, Mori S, et al: Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice. Int J Oncol 32: 1221-1226, 2008.
APA
Hachimine, D., Uchida, K., Asada, M., Nishio, A., Kawamata, S., Sekimoto, G. ... Okazaki, K. (2008). Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice. International Journal of Oncology, 32, 1221-1226. https://doi.org/10.3892/ijo.32.6.1221
MLA
Hachimine, D., Uchida, K., Asada, M., Nishio, A., Kawamata, S., Sekimoto, G., Murata, M., Yamagata, H., Yoshida, K., Mori, S., Tahashi, Y., Matsuzaki, K., Okazaki, K."Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice". International Journal of Oncology 32.6 (2008): 1221-1226.
Chicago
Hachimine, D., Uchida, K., Asada, M., Nishio, A., Kawamata, S., Sekimoto, G., Murata, M., Yamagata, H., Yoshida, K., Mori, S., Tahashi, Y., Matsuzaki, K., Okazaki, K."Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice". International Journal of Oncology 32, no. 6 (2008): 1221-1226. https://doi.org/10.3892/ijo.32.6.1221